316 related articles for article (PubMed ID: 10439039)
1. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
3. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
4. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
Benaud CM; Dickson RB
Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
[TBL] [Abstract][Full Text] [Related]
5. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21.
Cayrol C; Ducommun B
Oncogene; 1998 Nov; 17(19):2437-44. PubMed ID: 9824154
[TBL] [Abstract][Full Text] [Related]
6. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
Luo Y; Hurwitz J; Massagué J
Nature; 1995 May; 375(6527):159-61. PubMed ID: 7753174
[TBL] [Abstract][Full Text] [Related]
7. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
8. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
Medema RH; Klompmaker R; Smits VA; Rijksen G
Oncogene; 1998 Jan; 16(4):431-41. PubMed ID: 9484832
[TBL] [Abstract][Full Text] [Related]
9. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells.
Sekiguchi T; Hunter T
Oncogene; 1998 Jan; 16(3):369-80. PubMed ID: 9467962
[TBL] [Abstract][Full Text] [Related]
10. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
[TBL] [Abstract][Full Text] [Related]
11. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells.
Cayrol C; Knibiehler M; Ducommun B
Oncogene; 1998 Jan; 16(3):311-20. PubMed ID: 9467956
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
Gong J; Ammanamanchi S; Ko TC; Brattain MG
Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
[TBL] [Abstract][Full Text] [Related]
13. Proteasome-dependent regulation of p21WAF1/CIP1 expression.
Blagosklonny MV; Wu GS; Omura S; el-Deiry WS
Biochem Biophys Res Commun; 1996 Oct; 227(2):564-9. PubMed ID: 8878553
[TBL] [Abstract][Full Text] [Related]
14. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
Afshari CA; Nichols MA; Xiong Y; Mudryj M
Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
[TBL] [Abstract][Full Text] [Related]
15. p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells.
Strasberg Rieber M; Welch DR; Miele ME; Rieber M
Cell Growth Differ; 1996 Feb; 7(2):197-202. PubMed ID: 8822203
[TBL] [Abstract][Full Text] [Related]
16. Suppression of cancer cell growth by adenovirus expressing p21(WAF1/CIP1) deficient in PCNA interaction.
Prabhu NS; Blagosklonny MV; Zeng YX; Wu GS; Waldman T; El-Deiry WS
Clin Cancer Res; 1996 Jul; 2(7):1221-9. PubMed ID: 9816291
[TBL] [Abstract][Full Text] [Related]
17. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
Goubin F; Ducommun B
Oncogene; 1995 Jun; 10(12):2281-7. PubMed ID: 7784076
[TBL] [Abstract][Full Text] [Related]
18. Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells.
Poon RY; Hunter T
Oncogene; 1998 Mar; 16(10):1333-43. PubMed ID: 9546435
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
Li Y; Jenkins CW; Nichols MA; Xiong Y
Oncogene; 1994 Aug; 9(8):2261-8. PubMed ID: 7913544
[TBL] [Abstract][Full Text] [Related]
20. Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells.
Lu Y; Yamagishi N; Yagi T; Takebe H
Oncogene; 1998 Feb; 16(6):705-12. PubMed ID: 9488034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
